Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 29, 2020
Tjoapack Netherlands announced a majority investment from Ampersand Capital Partners, a private equity firm.
read more
Wednesday, April 29, 2020
A collaboration to accelerate the development of a lead COVID-19 drug candidate into human clinical trials has been announced by Quotient Sciences and CytoAgents.
read more
Wednesday, April 29, 2020
DuPont has entered into an exclusive agreement with CCT for the global production, sales, distribution, and technical service of Tyvek® Cargo Covers for the life sciences.
read more
NanoPass is collaborating with vaccine and immunotherapy companies around the world and is sharing its proprietary MicronJet microneedle device to enable development of a safe, effective and affordable vaccine.
read more
MedPharm has expanded its innovative testing models to support pharmaceutical development programs targeting Coronavirus treatments.
read more
Clearside Biomedical announced an update to the XIPERE NDA resubmission timeline and to its commercialization and development partnership with Bausch Health and Bausch + Lomb, its global eye health business.
read more
International Pharmaceutical Expo (INTERPHEX) has announced the next edition of INTERPHEX, previously postponed to July 2020, will now take place April 20-22, 2021 at the Javits Center in New York. The 2020 dates are cancelled.
read more
Trio and Ajinomoto Bio-Pharma announced a development collaboration agreement to evaluate AJICAP for the development of TDCs.
read more
Clinical Ink has announced a wide-ranging Study Assurance Program to minimize financial impact of the disruption from COVID-19 on new and existing clinical trials.
read more
ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.
read more
Review the latest news and information on the Coronavirus Pandemic.
read more
Key Biologics and Astarte Biologics announced the launch of an IRB-approved initiative to support the research, therapeutic, and vaccine communities with access to blood products collected from COVID-19 convalescent donors.
read more
PrecisionLife is extending its relationships with some of the COVID-19 collaborative research projects and is offering free use of its analytics platform.
read more
Aravive and WuXi Biologics announced a strategic collaboration agreement granting Aravive the right to use the proprietary WuXiBody™ platform to develop high-affinity bispecific antibodies for a target implicated in cancer and fibrosis.
read more
Ajinomoto Bio-Pharma Services has entered into a manufacturing services agreement with CytoDyn for the supply of the investigational new drug, leronlimab.
read more